IntegraGen (Paris:ALINT) announced that it has entered into an agreement with Pfizer Inc. (NYSE:PFE) that provides Pfizer access to evaluate the company’s proprietary molecular signature for hepatocellular carcinoma. The 56-gene molecular signature covered by the agreement is intended to predict the clinical prognosis of patients with hepatocellular carcinoma and subcategorize patients into six separate classifications based on the molecular characteristics of their liver tumors. Pfizer Inc. (NYSE:PFE) shares after opening at $31.92 on last trade day and at the end of the day closed at $32.29. Company price to sales ratio in past twelve months was calculated as 4.00 and price to cash ratio as 6.37. Pfizer Inc. (NYSE:PFE) showed a positive weekly performance of 0.34%.
Gilead Sciences, Inc. (NASDAQ:GILD) said topline results from a Phase 3 clinical trial in Japan involving the company’s hepatitis C pill, sofosbuvir, in combination with ribavirin showed the study met its primary efficacy endpoint. Based on the trial results, Gilead expects to submit a new drug application for sofosbuvir to the Japanese Pharmaceutical and Medical Devices Agency by mid-2014, said Norbert Bischofberger, Gilead’s chief scientific officer and executive vice president of research and development. Gilead Sciences, Inc. (NASDAQ:GILD) shares fell 0.43% in last trading session and ended the day on $73.96. GILD return on equity ratio is recorded as 28.30% and its return on assets is 13.70%. Gilead Sciences, Inc. (NASDAQ:GILD) yearly performance is 55.28%.
On April 1, 2014 – Johnson & Johnson (NYSE:JNJ) has acquired Stateside Underwriting Agency, Inc (SUA). Johnson & Johnson is a fourth generation, family owned managing general agency based in Charleston, South Carolina. Founded in 1930, the company recently celebrated its 80th anniversary of providing superior service and products to Independent Agents while maintaining its family culture. Under its new ownership, SUA will continue to offer the same first-class products and services as it has in the past. SUA has offices located in Crystal Lake, IL and Chagrin Falls, OH. Johnson & Johnson (NYSE:JNJ) shares moved up 0.30% in last trading session and was closed at $98.23, while trading in range of $97.37 – $98.39. Johnson & Johnson (NYSE:JNJ) year to date (YTD) performance is 8.02%.
On March 30, Merck & Co., Inc. (NYSE:MRK)’s long-time chief financial officer Peter Kellogg is to step down within the next two months and will be replaced by Baxter’s Robert Davis. Merck & Co., Inc. (NYSE:MRK) weekly performance is 0.79%. On last trading day company shares ended up $56.46. Merck & Co., Inc. (NYSE:MRK) distance from 50-day simple moving average (SMA50) is 3.03%. Analysts mean target price for the company is $56.78.
Leave a Reply